Desogestrel And Ethinyl Estradiol
Generic Name: desogestrel and ethinyl estradiol
Brand Names:
Desogestrel And Ethinyl Estradiol
Desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg provide an oral contraceptive regimen of 21 light orange round tablets each containing 0.15 mg desogestrel and 0.03 mg ethinyl estradiol.
Overview
Desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg provide an oral contraceptive regimen of 21 light orange round tablets each containing 0.15 mg desogestrel and 0.03 mg ethinyl estradiol.
Uses
Indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Dosage
Take one light orange active tablet daily for 21 days, then one green reminder tablet daily for 7 days. Patients should follow either Day 1 or Sunday start regimens as directed by their healthcare provider.
Side Effects
Common effects include nausea, vomiting, breakthrough bleeding, and spotting. Serious conditions include thrombophlebitis, myocardial infarction, pulmonary embolism, and cerebral hemorrhage.
Interactions
Enzyme inducers like rifampicin and St. John's wort may decrease effectiveness. CYP3A4 inhibitors may increase hormone concentrations. Should not be combined with ombitasvir/paritaprevir/ritonavir due to liver enzyme elevation risk.
Warnings
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age. Contraindicated in patients with thrombophlebitis, cerebrovascular disease, valvular heart disease, uncontrolled hypertension, current breast cancer, hepatic disease, undiagnosed vaginal bleeding.
Pregnancy
Extensive epidemiological studies have revealed no increased risk of birth defects in women who have used oral contraceptives prior to pregnancy. The medication should be discontinued if pregnancy is confirmed.
Storage
Store at 25 degrees C (77 degrees F); excursions permitted to 15 to 30 degrees C (59 to 86 degrees F).
Frequently Asked Questions
What is Desogestrel And Ethinyl Estradiol used for?▼
Indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
What are the side effects of Desogestrel And Ethinyl Estradiol?▼
Common effects include nausea, vomiting, breakthrough bleeding, and spotting. Serious conditions include thrombophlebitis, myocardial infarction, pulmonary embolism, and cerebral hemorrhage.
Can I take Desogestrel And Ethinyl Estradiol during pregnancy?▼
Extensive epidemiological studies have revealed no increased risk of birth defects in women who have used oral contraceptives prior to pregnancy. The medication should be discontinued if pregnancy is confirmed.
What are the important warnings for Desogestrel And Ethinyl Estradiol?▼
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age. Contraindicated in patients with thrombophlebitis, cerebrovascular disease, valvular heart disease, uncontrolled hypertension, current breast cancer, hepatic disease, undiagnosed vaginal bleeding.
Related Medications
Motionsense Dry Spray Basil And Lavender 48h Antiperspirant Deodorant
motionsense dry spray basil and lavender 48h antiperspirant deodorant
Purpose antiperspirant
Aluminum Hydroxide, Magnesium Hydroxide, And Dimethicone
aluminum hydroxide, magnesium hydroxide, and dimethicone
Purpose Antacid/Antigas
Axatilimab-csfr
axatilimab-csfr
Colony Stimulating Factor-1 Receptor Blocker [EPC]
11 DESCRIPTION Axatilimab-csfr is a CSF-1R–blocking antibody. Axatilimab-csfr is a humanized IgG4 (kappa light chain) monoclonal antibody produced in Chinese hamster ovary cells. Axatilimab-csfr has an approximate molecular weight of 150 kDa. NIKTIMVO (axatilimab-csfr) injection is a sterile, preservative-free, slightly opalescent, pale brownish yellow solution for intravenous use. The solution is free from visible particles.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.